Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C2H3O2.Al.HO |
Molecular Weight | 162.0769 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[Al+3].CC([O-])=O.CC([O-])=O
InChI
InChIKey=HQQUTGFAWJNQIP-UHFFFAOYSA-K
InChI=1S/2C2H4O2.Al.H2O/c2*1-2(3)4;;/h2*1H3,(H,3,4);;1H2/q;;+3;/p-3
DescriptionSources: http://www.domeboro.com/about-domeboro/Curator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Sources: http://www.domeboro.com/about-domeboro/
Curator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate.
The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.
Originator
Sources: http://www.domeboro.com/about-domeboro/
Curator's Comment: Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2364031 |
|||
Target ID: GO:0042310 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | DOMEBORO Approved UseTemporarily relieves minor skin irritations due to:
– Poison ivy | – Poison oak
– Poison sumac | – Insect bites
– Athlete’s foot | – Rashes caused by soaps, detergents, cosmetics, or jewelry |
|||
Curative | DOMEBORO Approved UseThis medication is used to treat an outer ear infection (external otitis). This product contains acetic acid/aluminum acetate, a combination that stops the growth of bacteria and fungus. Treating the infection reduces pain and swelling in the ear. Wetness in the ear canal can help bacteria and fungus to grow. This medication also causes drying of the ear canal, helping to cure the infection. |
PubMed
Title | Date | PubMed |
---|---|---|
Cardiovascular manifestations of aluminium phosphide intoxication. | 1989 Sep |
|
The antibacterial activity of acetic acid and Burow's solution as topical otological preparations. | 1998 Oct |
|
Effect of aluminum phosphide on blood glucose level. | 1999 Feb |
|
Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. | 2002 |
|
Final report on the safety assessment of aluminum silicate, calcium silicate, magnesium aluminum silicate, magnesium silicate, magnesium trisilicate, sodium magnesium silicate, zirconium silicate, attapulgite, bentonite, Fuller's earth, hectorite, kaolin, lithium magnesium silicate, lithium magnesium sodium silicate, montmorillonite, pyrophyllite, and zeolite. | 2003 |
|
The giant protein HERC1 is recruited to aluminum fluoride-induced actin-rich surface protrusions in HeLa cells. | 2004 Feb 13 |
|
Aluminum: new recognition of an old problem. | 2005 Dec |
|
Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. | 2005 Nov |
|
An effector domain mutant of Arf6 implicates phospholipase D in endosomal membrane recycling. | 2006 Jan |
|
Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. | 2007 Oct |
|
Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. | 2007 Sep-Oct |
|
Hyperglycemia in acute aluminum phosphide poisoning as a potential prognostic factor. | 2008 Jul |
|
Aluminum phosphide fatalities at mild exertion in asymptomatic children: a clue to understand the variations of the autopsy findings. | 2009 Aug |
|
Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): the key metric of dose is particle mass and not particle surface area. | 2009 May 17 |
|
Altered glucose homeostasis in response to aluminium phosphide induced cellular oxygen deficit in rat. | 2010 Jul |
|
Blood levels of methemoglobin in patients with aluminum phosphide poisoning and its correlation with patient's outcome. | 2011 Mar |
|
Molecular basis of carcinogenicity of tungsten alloy particles. | 2015 Mar 15 |
Sample Use Guides
DOMEBORO® SOOTHING SOAK
– dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water
– stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use
For use as a soak:
– soak affected area for 15 to 30 minutes as needed, or as directed by a doctor
– repeat 3 times a day or as directed by a doctor
– discard solution after each use.
For use as a compress or wet dressing:
– soak a clean, soft cloth in the solution.
– apply cloth loosely to affected area for 15 to 30 minutes
– repeat as needed or as directed by a doctor
– discard solution after each use
Route of Administration:
Topical
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB12821MIG
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
CONCEPT | Industrial Aid | ||
|
300000031249
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
205-518-2
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
FGL8577C9S
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
DB15679
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
FGL8577C9S
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
10197832
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
m1629
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | Merck Index | ||
|
ALUMINIUM DIACETATE
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
SUB91977
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
DTXSID7044552
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
142-03-0
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | |||
|
235461
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY | RxNorm | ||
|
C77451
Created by
admin on Fri Dec 15 15:54:30 UTC 2023 , Edited by admin on Fri Dec 15 15:54:30 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD